Trypanosoma cruzi Reactivation After Chimeric Antigen Receptor T-Cell Therapy

被引：0
|
作者：
Alahmdi, Bayan [1 ]
Kaur, Avneet [2 ]
Jacobs, Samantha E. [3 ]
Sullivan, Timothy [3 ]
Barghash, Maya [4 ]
Taimur, Sarah [3 ]
机构：
[1] King Abdulaziz Univ, Dept Med, Div Infect Dis, Jeddah, Saudi Arabia
[2] City Hope Natl Med Ctr, Dept Med, Div Infect Dis, Duarte, CA USA
[3] Icahn Sch Med Mt Sinai, Div Infect Dis, 1 Gustave L Levy Pl, New York, NY 10029 USA
[4] Icahn Sch Med Mt Sinai, Div Cardiol, New York, NY 10029 USA
来源：
OPEN FORUM INFECTIOUS DISEASES | 2024年 / 11卷 / 01期
关键词：
chimeric antigen receptor T-cell therapy; diffuse large B-cell lymphoma; hematopoietic cell transplant; Trypanosoma cruzi; CHAGAS-DISEASE; INFECTIOUS COMPLICATIONS; BENZNIDAZOLE; PATIENT;
D O I：
10.1093/ofid/ofad698
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
https://tidbitapp.io/tidbits/trypanosoma-cruzi-reactivation-post-chimeric-antigen-receptor-t-cell-therapy/update
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Role of bridging therapy during chimeric antigen receptor T cell therapy
    Bhaskar, Shakthi T.
    Dholaria, Bhagirathbhai R.
    Sengsayadeth, Salyka M.
    Savani, Bipin N.
    Oluwole, Olalekan O.
    EJHAEM, 2022, 3 : 39 - 45
  • [32] Neurotoxicity associated with cancer immunotherapy: immune checkpoint inhibitors and chimeric antigen receptor T-cell therapy
    Perrinjaquet, Claire
    Desbaillets, Nicolas
    Hottinger, Andreas F.
    CURRENT OPINION IN NEUROLOGY, 2019, 32 (03) : 500 - 510
  • [33] Chimeric Antigen Receptor T-cell Therapy Current Status and Clinical Outcomes in Pediatric Hematologic Malignancies
    Talleur, Aimee C.
    Myers, Regina
    Annesley, Colleen
    Shalabi, Haneen
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2022, 36 (04) : 701 - 727
  • [34] Advances in chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma
    Zixun Yin
    Ya Zhang
    Xin Wang
    Biomarker Research, 9
  • [35] Chimeric antigen receptor T-cell therapy: Prospective observational study of unplanned emergency department presentations
    Bak, Grace G.
    Micklethwaite, Kenneth
    Maddock, Karen
    Coggins, Andrew
    EMERGENCY MEDICINE AUSTRALASIA, 2023, 35 (06) : 1034 - 1037
  • [36] The Burden of Invasive Fungal Disease Following Chimeric Antigen Receptor T-Cell Therapy and Strategies for Prevention
    Little, Jessica S.
    Kampouri, Eleftheria
    Friedman, Daniel Z.
    Mccarty, Todd
    Thompson III, George R.
    Kontoyiannis, Dimitrios P.
    Vazquez, Jose
    Baddley, John W.
    Hammond, Sarah P.
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (06):
  • [37] Acute kidney injury following chimeric antigen receptor T-cell therapy: Epidemiology, mechanism and prognosis
    Yang, Yang
    Luo, Kaiping
    Xu, Gaosi
    CLINICAL IMMUNOLOGY, 2024, 266
  • [38] Next-Generation Implementation of Chimeric Antigen Receptor T-Cell Therapy Using Digital Health
    Banerjee, Rahul
    Shah, Nina
    Dicker, Adam P.
    JCO CLINICAL CANCER INFORMATICS, 2021, 5 : 668 - 678
  • [39] Chimeric Antigen Receptor T-Cell (CAR T-Cell) Therapy for Primary and Secondary Central Nervous System Lymphoma: A Systematic Review of Literature
    Asghar, Noureen
    Masood, Adeel
    Dhaliwal, Armaan
    Khurana, Sharad
    Davis, James
    Hashmi, Hamza
    Husnain, Muhammad
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (01) : 15 - 21
  • [40] Modulation of Trypanosoma cruzi-specific T-cell responses after chemotherapy for chronic Chagas disease
    Cecilia Albareda, Maria
    Adriana Laucella, Susana
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2015, 110 (03): : 414 - 421
12345